NCT06849063View on ClinicalTrials.gov

Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 9, 2020

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2026

Conditions
Pancreatic Cancer
Interventions
DIAGNOSTIC_TEST

magnetic resonance imaging

all participants undergo novel MR sequences, including 3D MRE#DCE-MRI#IVIM-DWI#T1/T2 mapping.

Trial Locations (1)

110004

RECRUITING

Shengjing hospital of China medical university, Shenyang

All Listed Sponsors
lead

Yu Shi

OTHER